Spasticity, what is the goal? Assessment, rehabilitation, and future perspectives.

about

Spasticity, what is the goal? Assessment, rehabilitation, and future perspectives.

Item

http://www.wikidata.org/entity/Q48056433

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Spasticity, what is the goal? Assessment, rehabilitation, and future perspectives.

@en

Spasticity, what is the goal? Assessment, rehabilitation, and future perspectives.

@nl

type

Item

label

Spasticity, what is the goal? Assessment, rehabilitation, and future perspectives.

@en

Spasticity, what is the goal? Assessment, rehabilitation, and future perspectives.

@nl

prefLabel

Spasticity, what is the goal? Assessment, rehabilitation, and future perspectives.

@en

Spasticity, what is the goal? Assessment, rehabilitation, and future perspectives.

@nl

P1476

Spasticity, what is the goal? Assessment, rehabilitation, and future perspectives.

@en

P2860

Non pharmacological interventions for spasticity in multiple sclerosis

Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity

Spasticity: clinical perceptions, neurological realities and meaningful measurement.

Results from the Upper Limb International Spasticity Study-II (ULISII):a large, international, prospective cohort study investigating practice and goal attainment following treatment with botulinum toxin A in real-life clinical management.

Common goal areas in the treatment of upper limb spasticity: a multicentre analysis.

Occurence and clinical predictors of spasticity after ischemic stroke.

Functional goal achievement in post-stroke spasticity patients: the BOTOX® Economic Spasticity Trial (BEST).

Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial.

Goal attainment for spasticity management using botulinum toxin.

Rivermead mobility index can be used to predict length of stay for elderly persons, 5 days after stroke onset.

P31

scholarly article

editorial

P356

10.1002/PRI.1686

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stephen Ashford

P577

2017-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28276178

http://www.w3.org/2001/XMLSchema#string